Testing version — LOERadar is in active testing. Features and data may change.
PROZAC (FLUOXETINE HYDROCHLORIDE) | LOERadar
PROZAC
NDA
FLUOXETINE HYDROCHLORIDE | N020974 | ELI LILLY AND CO
2 strengths0 unique patents0 unique exclusivities
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
Para IV certification filed but no ANDA patent litigation cases (NOS 835) matched from PACER. Litigation may be pending or filed under a different caption.
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (2)
Sort:
#001 — EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
RLD
0 patents0 exclusivities▴
TABLET;ORAL | Approved: Mar 9, 1999
No patent or exclusivity listings for this strength.
#002 — EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**